This strain contains 48 protein-level mutations:
We identified all possible linear viral peptides affected by these mutations. Whenever it was possible, we matched the reference peptide with the mutated one. For example, D -> L mutation transformed SDNGPQNQR to SLNGPQNQR. Cases when it was not meaningful included deletions and insertions at the flanks of the peptide, e.g., HV deletion in NVTWFHAIHV peptide.
Then, we predicted binding affinities between the selected peptides and frequent HLA alleles. Predictions were made with NetMHCpan-4.1 and NetMHCIIpan-4.0. The binding affinities were classifies into three groups:
Here we report HLA-peptide interactions whose affinity was altered by at least two folds. Note that mutations with empty set of altered interactions are not showed.
Weaker binding was found for 39 epitopes, while stronger binding was found for 58 entries. There are 363 tight binders for the HLA-A*02:06 in the reference immunopeptidome (IC50 affinity ≤ 50 nM); 6 of them became non-tight binders (1.6%) and 12 novel tight binders appeared (3.3%). To avoid possible divisions by zero, we used + 1 regularization term in denominators when calculating percentages.
Reference VFRSSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTKRFDNPVLPFNDGVYF
||||||||||||||||||||||||| |||||||||||||||||||||||||
Mutated VFRSSVLHSTQDLFLPFFSNVTWFHVI‑‑SGTNGTKRFDNPVLPFNDGVYF
| Allele | Reference peptide | Mutated peptide | Reference affinity (IC50, nM) | Mutated affinity (IC50, nM) |
|---|---|---|---|---|
| HLA-A*02:06 | VTWFHAIHV | VTWFHVI | 40 | - |
| HLA-A*02:06 | NVTWFHAIHV | NVTWFHVI | 263 | 10869 |
| HLA-A*02:06 | FSNVTWFHAIH | FSNVTWFHVI | 7820 | 387 |
| HLA-A*02:06 | FSNVTWFHA | FSNVTWFHV | 182 | 24 |
| HLA-A*02:06 | FFSNVTWFHA | FFSNVTWFHV | 972 | 227 |
| HLA-A*02:06 | SNVTWFHAI | SNVTWFHVI | 317 | 1145 |
| HLA-A*02:06 | FLPFFSNVTWFHA | FLPFFSNVTWFHV | 608 | 172 |
| HLA-A*02:06 | FLPFFSNVTWFHAI | FLPFFSNVTWFHVI | 457 | 1475 |
| HLA-A*02:06 | FSNVTWFHAI | FSNVTWFHVI | 123 | 387 |
Reference RSSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTKRFDNPVLPFNDGVYFAST
||||||||||||||||||||||||| |||||||||||||||||||||||||
Mutated RSSVLHSTQDLFLPFFSNVTWFHVI‑‑SGTNGTKRFDNPVLPFNDGVYFASI
| Allele | Reference peptide | Mutated peptide | Reference affinity (IC50, nM) | Mutated affinity (IC50, nM) |
|---|---|---|---|---|
| HLA-A*02:06 | VTWFHAIHV | VTWFHVI | 40 | - |
| HLA-A*02:06 | NVTWFHAIHV | NVTWFHVI | 263 | 10869 |
| HLA-A*02:06 | FSNVTWFHAIH | FSNVTWFHVI | 7820 | 387 |
Reference LLIVNNATNVVIKVCEFQFCNDPFLGVYYHKNNKSWMESEFRVYSSANNCTFE
||||||||||||||||||||||||| |||||||||||||||||||||||||
Mutated LLIVNNATNVVIKVCEFQFCNDPFL‑‑‑DHKNNKSWMESEFRVYSSANNCTFE
| Allele | Reference peptide | Mutated peptide | Reference affinity (IC50, nM) | Mutated affinity (IC50, nM) |
|---|---|---|---|---|
| HLA-A*02:06 | FQFCNDPFLGV | - | 7 | - |
| HLA-A*02:06 | EFQFCNDPFLGV | - | 87 | - |
| HLA-A*02:06 | FCNDPFLGV | FCNDPFL | 116 | - |
| HLA-A*02:06 | FQFCNDPFLGVY | - | 135 | - |
| HLA-A*02:06 | FQFCNDPFLG | - | 207 | - |
| HLA-A*02:06 | FQFCNDPFLGVYY | FQFCNDPFLD | 1024 | 258 |
Reference VNNATNVVIKVCEFQFCNDPFLGVYYHKNNKSWMESEFRVYSSANNCTFEY
||||||||||||||||||||||||| |||||||||||||||||||||||||
Mutated VNNATNVVIKVCEFQFCNDPFL‑‑‑DHKNNKSWMESEFRVYSSANNCTFEY
| Allele | Reference peptide | Mutated peptide | Reference affinity (IC50, nM) | Mutated affinity (IC50, nM) |
|---|---|---|---|---|
| HLA-A*02:06 | FQFCNDPFLGVYY | FQFCNDPFLD | 1024 | 258 |
Reference RFASVYAWNRKRISNCVADYSVLYNSASFSTFKCYGVSPTKLNDLCFTNVY
||||||||||||||||||||||||| |||||||||||||||||||||||||
Mutated RFASVYAWNRKRISNCVADYSVLYNLAPFFTFKCYGVSPTKLNDLCFTNVY
| Allele | Reference peptide | Mutated peptide | Reference affinity (IC50, nM) | Mutated affinity (IC50, nM) |
|---|---|---|---|---|
| HLA-A*02:06 | NSASFSTFKCYGV | NLAPFFTFKCYGV | 2140 | 141 |
| HLA-A*02:06 | SVLYNSASF | SVLYNLAPF | 2112 | 217 |
| HLA-A*02:06 | YSVLYNSASF | YSVLYNLAPF | 2478 | 463 |
| HLA-A*02:06 | VLYNSASFST | VLYNLAPFFT | 710 | 312 |
Reference ASVYAWNRKRISNCVADYSVLYNSASFSTFKCYGVSPTKLNDLCFTNVYAD
||||||||||||||||||||||||| |||||||||||||||||||||||||
Mutated ASVYAWNRKRISNCVADYSVLYNLAPFFTFKCYGVSPTKLNDLCFTNVYAD
| Allele | Reference peptide | Mutated peptide | Reference affinity (IC50, nM) | Mutated affinity (IC50, nM) |
|---|---|---|---|---|
| HLA-A*02:06 | ASFSTFKCYGV | APFFTFKCYGV | 231 | 13051 |
| HLA-A*02:06 | NSASFSTFKCYGV | NLAPFFTFKCYGV | 2140 | 141 |
| HLA-A*02:06 | SVLYNSASF | SVLYNLAPF | 2112 | 217 |
| HLA-A*02:06 | YSVLYNSASF | YSVLYNLAPF | 2478 | 463 |
| HLA-A*02:06 | VLYNSASFST | VLYNLAPFFT | 710 | 312 |
Reference VYAWNRKRISNCVADYSVLYNSASFSTFKCYGVSPTKLNDLCFTNVYADSF
||||||||||||||||||||||||| |||||||||||||||||||||||||
Mutated VYAWNRKRISNCVADYSVLYNLAPFFTFKCYGVSPTKLNDLCFTNVYADSF
| Allele | Reference peptide | Mutated peptide | Reference affinity (IC50, nM) | Mutated affinity (IC50, nM) |
|---|---|---|---|---|
| HLA-A*02:06 | ASFSTFKCYGV | APFFTFKCYGV | 231 | 13051 |
| HLA-A*02:06 | FSTFKCYGV | FFTFKCYGV | 61 | 2768 |
| HLA-A*02:06 | NSASFSTFKCYGV | NLAPFFTFKCYGV | 2140 | 141 |
| HLA-A*02:06 | STFKCYGV | FTFKCYGV | 2045 | 328 |
| HLA-A*02:06 | VLYNSASFST | VLYNLAPFFT | 710 | 312 |
Reference LYRLFRKSNLKPFERDISTEIYQAGSTPCNGVEGFNCYFPLQSYGFQPTNGV
||||||||||||||||||||||||| |||||||||||||||||||||||||
Mutated LYRLFRKSNLKPFERDISTEIYQAGNKPCNGVAGFNCYFPLRSYSFRPTYGV
| Allele | Reference peptide | Mutated peptide | Reference affinity (IC50, nM) | Mutated affinity (IC50, nM) |
|---|---|---|---|---|
| HLA-A*02:06 | YQAGSTPCNGV | YQAGNKPCNGV | 39 | 146 |
Reference SNLKPFERDISTEIYQAGSTPCNGVEGFNCYFPLQSYGFQPTNGVGYQPYR
||||||||||||||||||||||||| |||||||||||||||||||||||||
Mutated SNLKPFERDISTEIYQAGNKPCNGVAGFNCYFPLRSYSFRPTYGVGHQPYR
| Allele | Reference peptide | Mutated peptide | Reference affinity (IC50, nM) | Mutated affinity (IC50, nM) |
|---|---|---|---|---|
| HLA-A*02:06 | EGFNCYFPL | AGFNCYFPL | 1266 | 185 |
| HLA-A*02:06 | VEGFNCYFPL | VAGFNCYFPL | 1553 | 310 |
| HLA-A*02:06 | GVEGFNCYFPL | GVAGFNCYFPL | 400 | 174 |
Reference ISTEIYQAGSTPCNGVEGFNCYFPLQSYGFQPTNGVGYQPYRVVVLSFELL
||||||||||||||||||||||||| |||||||||||||||||||||||||
Mutated ISTEIYQAGNKPCNGVAGFNCYFPLRSYSFRPTYGVGHQPYRVVVLSFELL
| Allele | Reference peptide | Mutated peptide | Reference affinity (IC50, nM) | Mutated affinity (IC50, nM) |
|---|---|---|---|---|
| HLA-A*02:06 | LQSYGFQPT | LRSYSFRPT | 339 | 27414 |
| HLA-A*02:06 | LQSYGFQPTNGV | LRSYSFRPTYGV | 249 | 2086 |
| HLA-A*02:06 | QSYGFQPTNGV | RSYSFRPTYGV | 1121 | 320 |
Reference EIYQAGSTPCNGVEGFNCYFPLQSYGFQPTNGVGYQPYRVVVLSFELLHAP
||||||||||||||||||||||||| |||||||||||||||||||||||||
Mutated EIYQAGNKPCNGVAGFNCYFPLRSYSFRPTYGVGHQPYRVVVLSFELLHAP
| Allele | Reference peptide | Mutated peptide | Reference affinity (IC50, nM) | Mutated affinity (IC50, nM) |
|---|---|---|---|---|
| HLA-A*02:06 | LQSYGFQPT | LRSYSFRPT | 339 | 27414 |
| HLA-A*02:06 | YGFQPTNGV | YSFRPTYGV | 174 | 10 |
| HLA-A*02:06 | SYGFQPTNGV | SYSFRPTYGV | 3944 | 455 |
| HLA-A*02:06 | LQSYGFQPTNGV | LRSYSFRPTYGV | 249 | 2086 |
| HLA-A*02:06 | QSYGFQPTNGV | RSYSFRPTYGV | 1121 | 320 |
Reference YQAGSTPCNGVEGFNCYFPLQSYGFQPTNGVGYQPYRVVVLSFELLHAPAT
||||||||||||||||||||||||| |||||||||||||||||||||||||
Mutated YQAGNKPCNGVAGFNCYFPLRSYSFRPTYGVGHQPYRVVVLSFELLHAPAT
| Allele | Reference peptide | Mutated peptide | Reference affinity (IC50, nM) | Mutated affinity (IC50, nM) |
|---|---|---|---|---|
| HLA-A*02:06 | LQSYGFQPT | LRSYSFRPT | 339 | 27414 |
| HLA-A*02:06 | YGFQPTNGV | YSFRPTYGV | 174 | 10 |
| HLA-A*02:06 | SYGFQPTNGV | SYSFRPTYGV | 3944 | 455 |
| HLA-A*02:06 | LQSYGFQPTNGV | LRSYSFRPTYGV | 249 | 2086 |
| HLA-A*02:06 | QSYGFQPTNGV | RSYSFRPTYGV | 1121 | 320 |
Reference GSTPCNGVEGFNCYFPLQSYGFQPTNGVGYQPYRVVVLSFELLHAPATVCG
||||||||||||||||||||||||| |||||||||||||||||||||||||
Mutated GNKPCNGVAGFNCYFPLRSYSFRPTYGVGHQPYRVVVLSFELLHAPATVCG
| Allele | Reference peptide | Mutated peptide | Reference affinity (IC50, nM) | Mutated affinity (IC50, nM) |
|---|---|---|---|---|
| HLA-A*02:06 | YGFQPTNGV | YSFRPTYGV | 174 | 10 |
| HLA-A*02:06 | SYGFQPTNGV | SYSFRPTYGV | 3944 | 455 |
| HLA-A*02:06 | LQSYGFQPTNGV | LRSYSFRPTYGV | 249 | 2086 |
| HLA-A*02:06 | QSYGFQPTNGV | RSYSFRPTYGV | 1121 | 320 |
Reference CNGVEGFNCYFPLQSYGFQPTNGVGYQPYRVVVLSFELLHAPATVCGPKKS
||||||||||||||||||||||||| |||||||||||||||||||||||||
Mutated CNGVAGFNCYFPLRSYSFRPTYGVGHQPYRVVVLSFELLHAPATVCGPKKS
| Allele | Reference peptide | Mutated peptide | Reference affinity (IC50, nM) | Mutated affinity (IC50, nM) |
|---|---|---|---|---|
| HLA-A*02:06 | YQPYRVVVL | HQPYRVVVL | 223 | 2206 |
| HLA-A*02:06 | YQPYRVVVLSFEL | HQPYRVVVLSFEL | 430 | 2495 |
Reference PCSFGGVSVITPGTNTSNQVAVLYQDVNCTEVPVAIHADQLTPTWRVYSTG
||||||||||||||||||||||||| |||||||||||||||||||||||||
Mutated PCSFGGVSVITPGTNTSNQVAVLYQGVNCTEVPVAIHADQLTPTWRVYSTG
| Allele | Reference peptide | Mutated peptide | Reference affinity (IC50, nM) | Mutated affinity (IC50, nM) |
|---|---|---|---|---|
| HLA-A*02:06 | DVNCTEVPV | GVNCTEVPV | 3807 | 208 |
| HLA-A*02:06 | QVAVLYQDV | QVAVLYQGV | 1312 | 148 |
| HLA-A*02:06 | YQDVNCTEV | YQGVNCTEV | 17 | 57 |
| HLA-A*02:06 | NQVAVLYQDV | NQVAVLYQGV | 36 | 18 |
Reference TPTWRVYSTGSNVFQTRAGCLIGAEHVNNSYECDIPIGAGICASYQTQTNS
||||||||||||||||||||||||| |||||||||||||||||||||||||
Mutated TPTWRVYSTGSNVFQTRAGCLIGAEYVNNSYECDIPIGAGICASYQTQTKS
| Allele | Reference peptide | Mutated peptide | Reference affinity (IC50, nM) | Mutated affinity (IC50, nM) |
|---|---|---|---|---|
| HLA-A*02:06 | HVNNSYECDIPI | YVNNSYECDIPI | 837 | 92 |
Reference AGFIKQYGDCLGDIAARDLICAQKFNGLTVLPPLLTDEMIAQYTSALLAGT
||||||||||||||||||||||||| |||||||||||||||||||||||||
Mutated AGFIKQYGDCLGDIAARDLICAQKFKGLTVLPPLLTDEMIAQYTSALLAGT
| Allele | Reference peptide | Mutated peptide | Reference affinity (IC50, nM) | Mutated affinity (IC50, nM) |
|---|---|---|---|---|
| HLA-A*02:06 | AQKFNGLTVL | AQKFKGLTVL | 85 | 182 |
Reference ALGKLQDVVNQNAQALNTLVKQLSSNFGAISSVLNDILSRLDKVEAEVQID
||||||||||||||||||||||||| |||||||||||||||||||||||||
Mutated ALGKLQDVVNHNAQALNTLVKQLSSKFGAISSVLNDIFSRLDKVEAEVQID
| Allele | Reference peptide | Mutated peptide | Reference affinity (IC50, nM) | Mutated affinity (IC50, nM) |
|---|---|---|---|---|
| HLA-A*02:06 | KQLSSNFGA | KQLSSKFGA | 62 | 269 |
| HLA-A*02:06 | SNFGAISSV | SKFGAISSV | 361 | 1100 |
| HLA-A*02:06 | KQLSSNFGAI | KQLSSKFGAI | 58 | 159 |
Reference AQALNTLVKQLSSNFGAISSVLNDILSRLDKVEAEVQIDRLITGRLQSLQT
||||||||||||||||||||||||| |||||||||||||||||||||||||
Mutated AQALNTLVKQLSSKFGAISSVLNDIFSRLDKVEAEVQIDRLITGRLQSLQT
| Allele | Reference peptide | Mutated peptide | Reference affinity (IC50, nM) | Mutated affinity (IC50, nM) |
|---|---|---|---|---|
| HLA-A*02:06 | SVLNDILSRLDKV | SVLNDIFSRLDKV | 162 | 37 |
| HLA-A*02:06 | SVLNDILSRL | SVLNDIFSRL | 206 | 66 |
Reference MADSNGTITVEELKKLLEQWNLVIGFLF
|| |||||||||||||||||||||||||
Mutated MAGSNGTITVEELKKLLEEWNLVIGFLF
| Allele | Reference peptide | Mutated peptide | Reference affinity (IC50, nM) | Mutated affinity (IC50, nM) |
|---|---|---|---|---|
| HLA-A*02:06 | MADSNGTITV | MAGSNGTITV | 355 | 772 |
Reference MADSNGTITVEELKKLLEQWNLVIGFLFLTWICLLQFAYANRNR
|||||||||||||||||| |||||||||||||||||||||||||
Mutated MAGSNGTITVEELKKLLEEWNLVIGFLFLTWICLLQFAYANRNR
| Allele | Reference peptide | Mutated peptide | Reference affinity (IC50, nM) | Mutated affinity (IC50, nM) |
|---|---|---|---|---|
| HLA-A*02:06 | EQWNLVIGFL | EEWNLVIGFL | 418 | 10916 |
| HLA-A*02:06 | LLEQWNLVI | LLEEWNLVI | 1869 | 487 |
Reference AYANRNRFLYIIKLIFLWLLWPVTLACFVLAAVYRINWITGGIAIAMACLV
||||||||||||||||||||||||| |||||||||||||||||||||||||
Mutated AYANRNRFLYIIKLIFLWLLWPVTLTCFVLAAVYRINWITGGIAIAMACLV
| Allele | Reference peptide | Mutated peptide | Reference affinity (IC50, nM) | Mutated affinity (IC50, nM) |
|---|---|---|---|---|
| HLA-A*02:06 | WLLWPVTLA | WLLWPVTLT | 60 | 302 |
| HLA-A*02:06 | TLACFVLAAV | TLTCFVLAAV | 16 | 45 |
| HLA-A*02:06 | TLACFVLAA | TLTCFVLAA | 40 | 107 |
| HLA-A*02:06 | FLWLLWPVTLA | FLWLLWPVTLT | 495 | 1240 |
| HLA-A*02:06 | LACFVLAAV | LTCFVLAAV | 51 | 23 |
Reference MYSFVSEETGTLIVNSVLLFLAFVVFLLVTLAIL
|||||||| |||||||||||||||||||||||||
Mutated MYSFVSEEIGTLIVNSVLLFLAFVVFLLVTLAIL
| Allele | Reference peptide | Mutated peptide | Reference affinity (IC50, nM) | Mutated affinity (IC50, nM) |
|---|---|---|---|---|
| HLA-A*02:06 | FVSEETGTLI | FVSEEIGTLI | 423 | 144 |
| HLA-A*02:06 | FVSEETGTL | FVSEEIGTL | 120 | 41 |
| HLA-A*02:06 | FVSEETGTLIV | FVSEEIGTLIV | 670 | 266 |
Reference MDPKISEMHPALRLVDPQIQLAVTRMENAVGRDQN
||||||||| |||||||||||||||||||||||||
Mutated MDPKISEMHSALRLVDPQIQLAVTRM‑‑‑VGRDQN
| Allele | Reference peptide | Mutated peptide | Reference affinity (IC50, nM) | Mutated affinity (IC50, nM) |
|---|---|---|---|---|
| HLA-A*02:06 | KISEMHPAL | KISEMHSAL | 62 | 310 |
Reference DPKISEMHPALRLVDPQIQLAVTRMENAVGRDQNNVGPKVYPIILRLGSPLSL
||||||||||||||||||||||||| |||||||||||||||||||||||||
Mutated DPKISEMHSALRLVDPQIQLAVTRM‑‑‑VGRDQNNVGPKVYPIILRLGSPLSL
| Allele | Reference peptide | Mutated peptide | Reference affinity (IC50, nM) | Mutated affinity (IC50, nM) |
|---|---|---|---|---|
| HLA-A*02:06 | IQLAVTRMENAV | IQLAVTRMV | 263 | 47 |
Reference ACCHLAKALNDFSNSGSDVLYQPPQTSITSAVLQ
||||||||||||||||||||||||| ||||||||
Mutated ACCHLAKALNDFSNSGSDVLYQPPQISITSAVLQ
| Allele | Reference peptide | Mutated peptide | Reference affinity (IC50, nM) | Mutated affinity (IC50, nM) |
|---|---|---|---|---|
| HLA-A*02:06 | QPPQTSITSAV | QPPQISITSAV | 3097 | 393 |
| HLA-A*02:06 | LYQPPQTSITSAV | LYQPPQISITSAV | 1485 | 214 |
| HLA-A*02:06 | YQPPQTSITSAV | YQPPQISITSAV | 156 | 26 |
Reference YFNMVYMPASWVMRIMTWLDMVDTSLSGFKLKDCVMYASAVVLLILMTARTVY
||||||||||||||||||||||||| |||||||||||||||||||||||||
Mutated YFNMVYMPASWVMRIMTWLDMVDTS‑‑‑FKLKDCVMYASAVVLLILMTARTVY
| Allele | Reference peptide | Mutated peptide | Reference affinity (IC50, nM) | Mutated affinity (IC50, nM) |
|---|---|---|---|---|
| HLA-A*02:06 | WLDMVDTSL | - | 63 | - |
| HLA-A*02:06 | MTWLDMVDTSLSGFKL | MTWLDMVDTSFKL | - | 265 |
| HLA-A*02:06 | RIMTWLDMVDTSL | - | 342 | - |
| HLA-A*02:06 | LDMVDTSLSGFKL | LDMVDTSFKL | 12977 | 187 |
| HLA-A*02:06 | WLDMVDTSLSGFKL | WLDMVDTSFKL | 4589 | 98 |
Reference MWALIISVTSNYSGVVTTVMFLARGIVFMCVEYCPIFFITGNTLQCIMLVY
||||||||||||||||||||||||| |||||||||||||||||||||||||
Mutated MWALIISVTSNYSGVVTTVMFLARGVVFMCVEYCPIFFITGNTLQCIMLVY
| Allele | Reference peptide | Mutated peptide | Reference affinity (IC50, nM) | Mutated affinity (IC50, nM) |
|---|---|---|---|---|
| HLA-A*02:06 | TTVMFLARGI | TTVMFLARGV | 259 | 49 |
| HLA-A*02:06 | TVMFLARGI | TVMFLARGV | 300 | 61 |
Reference CVNCLDDRCILHCANFNVLFSTVFPPTSFGPLVRKIFVDGVPFVVSTGYHF
||||||||||||||||||||||||| |||||||||||||||||||||||||
Mutated CVNCLDDRCILHCANFNVLFSTVFPLTSFGPLVRKIFVDGVPFVVSTGYHF
| Allele | Reference peptide | Mutated peptide | Reference affinity (IC50, nM) | Mutated affinity (IC50, nM) |
|---|---|---|---|---|
| HLA-A*02:06 | FPPTSFGPLV | FPLTSFGPLV | 3379 | 73 |
| HLA-A*02:06 | FNVLFSTVFPP | FNVLFSTVFPL | 1609 | 37 |
| HLA-A*02:06 | VLFSTVFPP | VLFSTVFPL | 368 | 10 |
| HLA-A*02:06 | NVLFSTVFPP | NVLFSTVFPL | 1611 | 66 |
| HLA-A*02:06 | ANFNVLFSTVFPP | ANFNVLFSTVFPL | 5191 | 304 |
| HLA-A*02:06 | NFNVLFSTVFPP | NFNVLFSTVFPL | 4220 | 274 |
| HLA-A*02:06 | FNVLFSTVFPPT | FNVLFSTVFPLT | 4868 | 388 |